Picture of STAAR Surgical logo

STAA — STAAR Surgical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Proxy advisory firm ISS recommends STAAR Surgical investors vote down Alcon deal

Oct 15 (Reuters) - Proxy advisory firm Institutional Shareholder Services on Wednesday recommended that investors in eye-care company STAAR Surgical vote against a planned deal with Alcon AG, arguing that pushback from big shareholders and other "deficiencies" speak against the proposed takeover.

STAAR's biggest investor Broadwood, which holds nearly 30% of the stock, has said it will vote against the proposal that the company will sell itself to Alcon for $28 a share. The vote is on October 23.

(Reporting by Svea Herbst-Bayliss and Maria Rugamer)

((svea.herbst@thomsonreuters.com; +617 233 2138; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net/))

Recent news on STAAR Surgical

See all news